Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Related Articles by Review for PubMed (Select 17409396)

1.

Mammalian tumor xenografts induce neovascularization in zebrafish embryos.

Nicoli S, Ribatti D, Cotelli F, Presta M.

Cancer Res. 2007 Apr 1;67(7):2927-31.

2.

Zebrafish embryo, a tool to study tumor angiogenesis.

Tobia C, De Sena G, Presta M.

Int J Dev Biol. 2011;55(4-5):505-9. doi: 10.1387/ijdb.103238ct. Review.

3.

Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk.

Tobia C, Gariano G, De Sena G, Presta M.

Biochim Biophys Acta. 2013 Sep;1832(9):1371-7. doi: 10.1016/j.bbadis.2013.01.016. Epub 2013 Jan 26. Review.

4.

The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy.

Lu B, Shinohara ET, Edwards E, Geng L, Tan J, Hallahan DE.

Technol Cancer Res Treat. 2005 Dec;4(6):691-8. Review.

PMID:
16292890
5.

Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.

Dutour A, Rigaud M.

Anticancer Res. 2005 Nov-Dec;25(6B):3799-807. Review. Erratum in: Anticancer Res. 2006 Jan-Feb;26(1a):445.

6.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
8.

Antiangiogenic cancer therapy.

Cao Y.

Semin Cancer Biol. 2004 Apr;14(2):139-45. Review.

PMID:
15018898
9.

III. Angiogenesis: complexity of tumor vasculature and microenvironment.

Furuya M, Yonemitsu Y, Aoki I.

Curr Pharm Des. 2009;15(16):1854-67. Review.

PMID:
19519428
10.

Tumor angiogenesis and therapy.

Cao Y.

Biomed Pharmacother. 2005 Oct;59 Suppl 2:S340-3. Review.

PMID:
16507405
11.

Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies.

Bussolati B, Deregibus MC, Camussi G.

Curr Vasc Pharmacol. 2010 Mar;8(2):220-32. Review.

PMID:
19485921
12.

Multifocal angiostatic therapy: an update.

McCarty MF, Block KI.

Integr Cancer Ther. 2005 Dec;4(4):301-14. Review.

PMID:
16282507
13.

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Ranieri G, Gasparini G.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. Review.

PMID:
12477290
14.

Zebrafish xenografts as a tool for in vivo studies on human cancer.

Konantz M, Balci TB, Hartwig UF, Dellaire G, André MC, Berman JN, Lengerke C.

Ann N Y Acad Sci. 2012 Aug;1266:124-37. doi: 10.1111/j.1749-6632.2012.06575.x. Review.

PMID:
22901264
15.

Antiangiogenic therapy for the treatment of pediatric solid malignancies.

Davidoff AM, Kandel JJ.

Semin Pediatr Surg. 2004 Feb;13(1):53-60. Review.

PMID:
14765371
16.

Modelling approaches for angiogenesis.

Taraboletti G, Giavazzi R.

Eur J Cancer. 2004 Apr;40(6):881-9. Review.

PMID:
15120043
17.

Heparin derivatives as angiogenesis inhibitors.

Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M.

Curr Pharm Des. 2003;9(7):553-66. Review.

PMID:
12570803
18.

Antiangiogenesis drug design: multiple pathways targeting tumor vasculature.

Zhong H, Bowen JP.

Curr Med Chem. 2006;13(8):849-62. Review.

PMID:
16611071
19.

Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development.

Goishi K, Klagsbrun M.

Curr Top Dev Biol. 2004;62:127-52. Review.

PMID:
15522741
20.

Embryonic stem cells: a novel tool for the study of antiangiogenesis and tumor-induced angiogenesis.

Wartenberg M, Dönmez F, Budde P, Sauer H.

Handb Exp Pharmacol. 2006;(174):53-71. Review.

PMID:
16370324
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk